Skip to main content
Equibles

Invesco Ltd.

Position in ALLO — Allogene Therapeutics, Inc.

CIK 914208 Atlanta, GA
Back to ALLO Full portfolio

Position in ALLO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,607,393
-$62,832 QoQ
Shares Held
772,786
+12.9% QoQ
Ownership
0.224%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 209 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 99% None 1%

Common Shares in ALLO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. ALLO ranks #125 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 8,043,052 $3,995,225,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,940,665 $2,457,162,245
3 ALNY
Alnylam Pharmaceuticals, Inc.
 3,754,318 $1,130,162,341
4 INCY
Incyte Corp
 4,080,461 $462,561,050
5 ARGX
Argenx SE
 443,990 $411,920,598
6 AXSM
Axsome Therapeutics, Inc.
 1,671,684 $409,178,086
7 MRNA
Moderna, Inc.
 5,780,299 $404,794,337
8 LGND
Ligand Pharmaceuticals Inc
 1,201,644 $379,827,645

All Filings in ALLO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,607,393 772,786
2026-03-31 $1,670,225 684,519
2025-12-31 $835,434 609,807
2025-09-30 $651,388 525,313
2025-06-30 $448,056 396,512
2025-03-31 $416,401 285,207
2024-12-31 $271,543 127,486
2024-09-30 $333,554 119,127
2024-06-30 $279,920 120,138
2024-03-31 $539,451 120,683
2023-12-31 $327,342 101,976
2023-09-30 $296,432 93,512
2023-06-30 $458,580 92,270
2023-03-31 $469,338 95,008
2022-12-31 $564,884 89,807
2022-09-30 $974,061 90,191
2022-06-30 $6,819,080 598,165
2022-03-31 $752,057 82,553
2021-12-31 $555,038 37,201
2021-09-30 $902,325 35,110
2021-06-30 $1,027,837 39,411
2021-03-31 $747,476 21,175
2020-12-31 $513,052 20,327
2020-09-30 $468,773 12,431
2020-06-30 $539,831 12,607
2020-03-31 $266,911 13,730